Veterinary IV solutions market seen reaching $2.36 billion by 2030

By AI, Created 10:34 AM UTC, May 20, 2026, /AGP/ – The veterinary intravenous solutions market is projected to grow from $1.75 billion in 2026 to $2.36 billion by 2030, driven by rising animal disease cases, more pet ownership and expanding emergency veterinary care. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Veterinary IV solutions are becoming a larger part of animal health care as clinics treat more dehydration, electrolyte imbalance and critical-care cases. - The market’s growth signals more spending on advanced veterinary treatment, especially for companion animals and emergency services.

What happened: - The Business Research Company published its Veterinary Intravenous (IV) Solutions Global Market Report 2026 covering market size, trends and forecasts through 2035. - The report estimates the market will grow from $1.62 billion in 2025 to $1.75 billion in 2026. - The report projects the market will reach $2.36 billion by 2030, implying a 7.7% compound annual growth rate. - North America held the largest share of the market in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - Veterinary IV solutions are sterile fluids delivered directly into an animal’s bloodstream through a vein, usually with an IV catheter. - The products are used to correct dehydration and electrolyte imbalances, deliver medications and provide nutrients. - The report ties recent growth to rising dehydration cases, more companion animals, more veterinary clinics and hospitals, broader use of traditional IV solutions and continued progress in veterinary fluid therapies. - The report says future growth will be supported by demand for advanced isotonic and colloid solutions, wider use of parenteral nutrition, specialized IV products for critical care and greater awareness of fluid therapy benefits. - The report highlights growth in balanced electrolyte and isotonic fluids, more synthetic and natural colloids, more parenteral nutrition products for companion and production animals, and wider use of ready-to-use and pre-mixed IV solutions. - The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report offers a free sample and the full market report.

Between the lines: - Rising animal disease incidence is one of the clearest demand drivers, because IV therapy is often needed when infections or gastrointestinal illness cause dehydration. - The release cites World Organisation for Animal Health data showing avian influenza outbreaks in mammals more than doubled in May 2025 versus 2023, with 1,022 occurrences across 55 countries compared with 459 the prior year. - Animal health spending is also rising, which supports wider adoption of veterinary treatments and products. - The release cites Republic of Estonia Agency of Medicines data showing the veterinary medicinal products market in Estonia grew 6.9% in 2023 to $20.54 million from $19.21 million in 2022. - The trend toward more specialized and ready-to-use IV products suggests veterinary care is becoming more standardized and more focused on critical cases.

What’s next: - The market is expected to keep expanding through 2030 as emergency and critical care services grow. - Product development is likely to center on balanced fluids, colloids, parenteral nutrition and pre-mixed IV solutions. - Regional growth momentum should remain strongest in Asia-Pacific as veterinary care access and demand broaden.